A major review published in the European Journal of Pediatrics has raised urgent concerns over rising antibiotic resistance in the treatment of neonatal sepsis. Titled “Antibiotic Strategies for Neonatal Sepsis: Navigating Efficacy and Emerging Resistance Patterns,” the study offers a comprehensive analysis of data from 8,954 neonates across 37 studies conducted between 2005 and 2024.
Dr. Ram Matoria, psychiatrist at North Western Railway Hospital, Jaipur, and Dr. Pankaj Soni, a senior pediatrician based in the UAE, co-authored the review.
Antibiotic Resistance Jeopardising Neonatal Survival
Dr. Matoria called the findings a wake-up call for global health systems. “Antibiotic resistance in neonates is a growing global threat that risks stalling the progress made in neonatal survival and public health,” he stated.
He stressed the urgent need to strengthen antibiotic stewardship programmes and to invest in local microbial surveillance systems, warning that the sustainability of current treatment protocols hangs in the balance.
Widespread Misuse of Antibiotics in Newborns
As reported by TOI, the review found that antibiotics such as ampicillin, gentamicin, and amikacin were most commonly prescribed as empirical treatments. For definitive therapy, vancomycin, amikacin, and meropenem were frequently used—even when no pathogen was identified (culture-negative cases).
This growing reliance on broad-spectrum antibiotics stems from several issues:
- Lack of rapid diagnostic tools
- Fear of missing early-onset sepsis
- Inconsistent adherence to treatment guidelines
- Limited availability of local antibiogram data
Resistance Rates Alarm Clinicians Worldwide
The study revealed concerning resistance patterns:
- Aminoglycoside resistance in 20% to 45% of cases
- Third-generation cephalosporin resistance ranging from 15% to 35%
- Carbapenem-resistant Gram-negative bacteria found in 10% of global cases
These findings underscore the shrinking pool of effective and safe antibiotics available for neonates. They also highlight the danger of continuing current practices without reform.
Call to Action for Global Health Stakeholders
With antibiotic resistance threatening to reverse advances in neonatal care, the study calls for immediate global action. Enhancing stewardship and improving diagnostic capabilities are critical. Generating robust local resistance data ensures newborns receive effective, responsible treatment.